{
    "nctId": "NCT01277133",
    "briefTitle": "An Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Metastatic Breast Cancer (CRONOS 2)",
    "officialTitle": "The Correlation Between the Moment of Bevacizumab theRapy initiatiOn and the Efficacy in patieNt With Metastatic Breast Cancer Treated With First Line Regimens Based On AvaStin",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 83,
    "primaryOutcomeMeasure": "Correlation between the time from start of chemotherapy to the start of Avastin treatment with progression-free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patients, \\>/=18 years of age\n* Previously untreated metastatic breast cancer\n* Scheduled to start 1st line chemotherapeutic treatment\n* ECOG performance status 0-1\n\nExclusion Criteria:\n\n* Any conditions included in contraindication list for Avastin\n* Prior chemotherapy for metastatic breast cancer\n* Adjuvant/neoadjuvant chemotherapy or radio-chemotherapy of non-metastatic malignancy completed \\<6 months prior to treatment start",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}